Pharmaceutical Uses
Product Pipeline
Therapeutic Areas
Research Data
References
Clinical Trials

References

Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol. May 2004; May;29:282-7.

Bhol KC, Schechter PJ. Suppressive effects of topical nanocrystalline silver on allergic contact dermatitis in mice.  Clin & Invest Med. Aug 2004; 27(4): 196A.

Bhol KC, Schechter PJ. Topical nanocrystalline silver cream inhibits expression of matrix metalloproteinase-9 in animal models of allergic contact dermatits.  J Invest Dermatol. April 2005; 124(4): A117.

Lyczak JB, Schechter PJ. Nanocrystalline silver inhibits antibiotic-, antiseptic-resistant bacteria. Clin Pharmacol Ther. 2005; 77:60.

Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Brit J Dermatol. 2005; 152:1235-1242.